6:28 PM
 | 
Nov 13, 2012
 |  BC Extra  |  Company News

RaQualia restructuring

RaQualia Pharma Inc. (JASDAQ:4579) said it will restructure and reduce headcount to focus on four compounds in development for gastrointestinal diseases. The company plans to reduce headcount by about 12 (14%) to 70 in 2013, including the elimination of nine R&D-related...

Read the full 188 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >